With experience delivering economic wastewater process technology to the pharmaceutical industry for nearly a decade, Headworks BIO enables pharmaceutical manufacturers to cost-effectively meet stringent regulatory discharge standards while maintaining focus on their core business.
Facing stringent discharge standards under the EPA Clean Water Act, pharmaceutical manufacturers increasingly rely on Headworks BIO Moving Bed Biofilm Reactor (MBBR) for reduction of target organics including acetone, isopropyl alcohol (IPA), benzene, MIBK, THF, and chlorobenzene.
Many organic solvents commonly used in the pharmaceutical industry are biodegradable and can be economically treated via the MBBR process. Resilient to process fluctuations and designed for automated operation, MBBR technology delivers highly efficient wastewater process capabilities optimized for the unique needs of the pharmaceutical industry.
